Efbemalenograstim Alfa for Primary/Secondary Prevention in Patients With Solid Tumors at High Risk for Febrile Neutropenia (FN) or Intermediate Risk of Chemotherapy Regimens Associated With Other Risk Factors in FN
Henan Cancer Hospital
Henan Cancer Hospital
Oncology Institute of Vojvodina
Anhui Provincial Hospital
Department of Medical Services Ministry of Public Health of Thailand
University Hospital, Angers
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology
Hospital General de Mexico
National Cancer Center, Korea
Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.
University Hospital, Angers
National Cancer Center, Korea
East and North Hertfordshire NHS Trust
Burnasyan Federal Medical Biophysical Center
Tel-Aviv Sourasky Medical Center